Allscripts Healthcare Solutions, Inc. (MDRX)

NASDAQ: MDRX · Delayed Price · USD
17.30
0.25 (1.47%)
At close: May 25, 2022 4:00 PM
17.49
0.19 (1.10%)
After-hours:May 25, 2022 5:29 PM EDT
Market Cap2.01B
Revenue (ttm)1.28B
Net Income (ttm)148.24M
Shares Out116.02M
EPS (ttm)1.10
PE Ratio15.78
Forward PE17.99
Dividendn/a
Ex-Dividend Daten/a
Volume1,527,124
Open17.01
Previous Close17.05
Day's Range16.87 - 17.58
52-Week Range13.05 - 23.25
Beta0.98
AnalystsBuy
Price Target23.91 (+38.2%)
Earnings DateMay 5, 2022

About MDRX

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated...

IndustryHealth Care Technology
Founded1986
CEOPaul Black
Employees8,000
Stock ExchangeNASDAQ
Ticker SymbolMDRX
Full Company Profile

Financial Performance

In 2021, MDRX's revenue was $1.50 billion, an increase of 0.02% compared to the previous year's $1.50 billion. Earnings were $134.44 million, a decrease of -80.81%.

Financial Statements

Analyst Forecast

According to 17 analysts, the average rating for MDRX stock is "Buy." The 12-month stock price forecast is 23.91, which is an increase of 38.21% from the latest price.

Price Target
$23.91
(38.21% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Veradigm Presentations at ISPOR 2022 Highlight Broader Access to and Integration of Real-world Data Sources

CHICAGO--(BUSINESS WIRE)--Researchers from Veradigm®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, diabete...

2 weeks ago - Business Wire

Allscripts' (MDRX) Stock Falls 8.8% Post Q1 Earnings Miss

Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.

2 weeks ago - Zacks Investment Research

AllScripts Healthcare (MDRX) Q1 Earnings and Revenues Lag Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

Allscripts Announces First Quarter of 2022 Results

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2022. First quarter 2022 Veradigm revenue...

2 weeks ago - Business Wire

Allscripts Closes Sale of Hospital and Large Physician Practices Business to Constellation Software

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) today announced that it has completed the sale of the net assets of the Allscripts Hospital and Large Physician Practices bu...

3 weeks ago - Business Wire

Here's Why You Should Retain Allscripts (MDRX) Stock For Now

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

1 month ago - Zacks Investment Research

Allscripts to Release First-Quarter 2022 Financial Results May 5

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) will report its financial results for the three months ended March 31, 2022 after the close of stock market hours on Thursda...

1 month ago - Business Wire

Are You Looking for a Top Momentum Pick? Why AllScripts Healthcare (MDRX) is a Great Choice

Does AllScripts Healthcare (MDRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

2 months ago - Zacks Investment Research

Reasons to Add Allscripts (MDRX) Stock to Your Portfolio

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

2 months ago - Zacks Investment Research

Surging Earnings Estimates Signal Upside for AllScripts (MDRX) Stock

AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

2 months ago - Zacks Investment Research

Medical IT Providers Marching to Their Own Beat

Medical IT Providers Marching to Their Own Beat

Other symbols:CHNG
2 months ago - Zacks Investment Research

Allscripts (MDRX) Unveils Newly Rebranded App Expo Site

Allscripts' (MDRX) rebranded App Expo site to offer developers an opportunity to present their certified solutions online.

2 months ago - Zacks Investment Research

Allscripts (MDRX) Up 4.5% Since Q4 Earnings: What's Driving It?

Allscripts' (MDRX) stock rallies on better-than-expected fourth-quarter performance and recent alliances.

2 months ago - Zacks Investment Research

Allscripts (MDRX) Inks Divestment Deal to Focus on Core Wing

Constellation Software will purchase the net assets of Allscripts' (MDRX) Hospitals and Large Physician Practices business segment via its wholly-owned subsidiary.

2 months ago - Zacks Investment Research

4 Stocks in Spotlight With AI Making Inroads in MedTech

MedTech stocks like Medtronic (MDT), Stryker (SYK), Allscripts Healthcare Solutions (MDRX) and Syneos Health (SYNH) are evolving rapidly in the field of AI-driven technologies.

Other symbols:MDTSYKSYNH
2 months ago - Zacks Investment Research

Allscripts Introduces New App Expo to Showcase a Broader Range of Integrated Solutions

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) announced today that its Application Store has been relaunched as the Allscripts App Expo The rebrand will ensure Allscripts clients have an engaging ...

2 months ago - Business Wire

Constellation Software's Harris Operating Group Acquires Allscripts Hospitals and Large Physician Practices Business ...

TORONTO, March 02, 2022 (GLOBE NEWSWIRE) -- Constellation Software Inc. (“Constellation”) (TSX:CSU) announced today that it has, through its wholly-owned subsidiary, N. Harris Computer Corporation (“Har...

2 months ago - GlobeNewsWire

Allscripts to Sell the Net Assets of Its Hospitals & Large Physician Practices Business Segment to Constellation Soft...

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ: MDRX) (“Allscripts”) announced today that it has reached an agreement with Constellation Software Inc. (TSX:CSU), through its wholly-ow...

2 months ago - Business Wire

Allscripts' (MDRX) Q4 Earnings Beat Estimates, Margins Up

Allscripts' (MDRX) robust Q4 results demonstrate strength in both segments.

3 months ago - Zacks Investment Research

AllScripts Healthcare (MDRX) Q4 Earnings and Revenues Surpass Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of 154.84% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Allscripts Announces Fourth Quarter and Fiscal Year 2021 Results

CHICAGO--(BUSINESS WIRE)---- $MDRX--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and twelve months ended December 31, 2021. Bookings(1)...

3 months ago - Business Wire

AllScripts Healthcare (MDRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

AllScripts (MDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

3 Medical Info Systems Stocks Braving Industry-wide Headwinds

Medical Info Systems stocks like Change Healthcare (CHNG), Allscripts Healthcare Solutions (MDRX) and Computer Programs and Systems, Inc. (CPSI) are expected to gain despite pandemic-led disruptions.

Other symbols:CHNGCPSI
3 months ago - Zacks Investment Research

Why AllScripts (MDRX) is Poised to Beat Earnings Estimates Again

AllScripts (MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

Allscripts (MDRX) Reports Solid Preliminary Q4 Revenues

Allscripts' (MDRX) revenue growth in the fourth quarter is likely to have been boosted by solid segmental performances.

3 months ago - Zacks Investment Research